The company now offers Isolexx canola isolates and Vitalexx hydrolyzed canola protein.
BioExx Specialty Proteins Ltd. (BioExx; Toronto) is officially in the market of commercialized canola-oil based protein, the company announced earlier this month.
Claiming to be the world’s first commercial producer of canola oil-based protein isolates and hydrolysates, the company began producing its Isolexx brand canola protein isolates in November. Vitalexx brand hydrolyzed canola protein will also be available.
Canola is the second largest crop grown in Canada, according to BioExx, and this protein source has plenty to offer for nutrition formulations. Canola oil provides over 100% of an adult’s required essential amino acid intake, says the company, noting that its ingredients are also free of phytoestrogens and genetic modification.
With processing plants in Saskatchewan, Canada and Minot, North Dakota, BioExx controls the entire production of its canola protein ingredients from crush and meal production to extraction of the protein.
For more information on canola protein, visit the company here.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.